Scinai Immunotherapeutics (SCNI) EPS (Basic) Growth (3y) (2017 - 2026)
Scinai Immunotherapeutics (SCNI) EPS (Basic) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | -38.31% |
| 10 | Scinai Immunotherapeutics | 12.17 Mn | -3.10 Bn | -1.12 Mn | -27.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.17% |
| Jun 30, 2025 | -26.07% |
| Mar 31, 2025 | 79.95% |
| Dec 31, 2024 | -26.30% |
| Sep 30, 2024 | 26.02% |
| Jun 30, 2024 | 86.36% |
| Mar 31, 2024 | 26.07% |
| Dec 31, 2023 | 78.15% |
| Sep 30, 2023 | -25.99% |
| Mar 31, 2023 | 26.07% |
| Sep 30, 2022 | 99.70% |
| Jun 30, 2022 | -57.80% |
| Mar 31, 2022 | 76.60% |
| Dec 31, 2021 | 26.05% |
| Sep 30, 2021 | -26.57% |
| Jun 30, 2021 | 27.08% |
| Mar 31, 2021 | 46.71% |
| Dec 31, 2020 | 38.46% |
| Mar 31, 2020 | -34.42% |
| Mar 31, 2019 | -60.64% |